23 November 2015 - A United Nations-backed organization working to cut the price of HIV drugs said it had signed a deal with Bristol-Myers Squibb to allow generic versions of the company's hepatitis C drug to be sold in 112 low- and middle-income countries.

For more details, go to: http://www.reuters.com/article/2015/11/23/us-bristol-myers-hepatitis-idUSKBN0TC1GD20151123?feedType=nl&feedName=healthNews#01foS5mYEfBsmhUE.97